Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.

Pharmaceutical

Shilpa Medicare Ltd

Vishnukant C. Bhutada

Smita Holey

Ganeshchandra Sonavane

Seshu A Akula

R K Somani

Sharath Reddy

K. H. Honneshaiah

V. Prakash

Jayant Karajgi

Alpesh Dalal

Leadership Team

Operations and Supply Chain Team

��

Teams at Shilpa Medicare Ltd

Leadership Team

Operations and Supply Chain Team

��������

Teams at Shilpa Medicare Ltd

Leadership Team

Operations and Supply Chain Team

��